Oliver Lagore Vanvalin Investment Group’s Idexx Laboratories IDXX Stock Holding History

Oliver Lagore Vanvalin Investment Group’s Portfolio IDXX Stock Details IDXX Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2025 Q2	$1.03M	Buy	+2,461	New	+$1.18M	0.41%	61
2024 Q4	$1.52M	Buy	3,683 +838	+29%	+$368K	0.39%	53
2024 Q3	$1.44M	Buy	+2,845	New	+$1.38M	0.38%	58
2022 Q4	–	Sell	-1	Closed	–	–	717
2022 Q3	$0	Hold	1	–	–	﹤0.01%	675
2022 Q2	$0	Buy	+1	New	+$408	﹤0.01%	657

Other funds holding IDXX

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Fundsmith LLP London, United Kingdom $12.8B AUM 6.9% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

BAMCO Inc New York $33.1B AUM 11.16% 1-Year Est. Return

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

Bank of New York Mellon New York $544B AUM 28.31% 1-Year Est. Return

Polen Capital Management Boca Raton, Florida $14.5B AUM 5.7% 1-Year Est. Return

Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return

Oliver Lagore Vanvalin Investment Group's IDXX Position: Q2 2025 in Review

Oliver Lagore Vanvalin Investment Group opened a new position in Idexx Laboratories (IDXX) in Q2 2025: 2,461 shares worth $1.03M. The stake represents 0.41% of the portfolio and ranks #61 among its holdings. This is a return to the name: Oliver Lagore Vanvalin Investment Group previously reported a position in IDXX as recently as Q4 2024.

Oliver Lagore Vanvalin Investment Group first reported a position in IDXX in Q2 2022 and has held it in 5 quarters since. The position peaked at $1.52M in Q4 2024. 1,235 funds tracked by Wall St. Rank hold IDXX as of Q2 2025.

Oliver Lagore Vanvalin Investment Group held 2,461 shares of Idexx Laboratories worth $1.03M as of Q2 2025.
Idexx Laboratories was a new Oliver Lagore Vanvalin Investment Group position in Q2 2025.
Idexx Laboratories made up 0.41% of Oliver Lagore Vanvalin Investment Group's portfolio in Q2 2025, its #61 holding.
Oliver Lagore Vanvalin Investment Group first reported a position in Idexx Laboratories in Q2 2022 and has held it in 5 quarters since.
Oliver Lagore Vanvalin Investment Group's Idexx Laboratories position peaked at $1.52M in Q4 2024.
1,235 funds tracked by Wall St. Rank held Idexx Laboratories as of Q2 2025.

Based on Oliver Lagore Vanvalin Investment Group's 13F filing for Q2 2025, filed 10 Jul 2025.